Mackenzie Financial’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,293
Closed -$44K 1536
2021
Q4
$44K Buy
+28,293
New +$46.7K ﹤0.01% 1404
2021
Q3
Sell
-19,557
Closed -$51K 1499
2021
Q2
$51K Buy
+19,557
New +$36.4K ﹤0.01% 1220
2021
Q1
Sell
-24,605
Closed -$32K 1223
2020
Q4
$32K Hold
24,605
﹤0.01% 1033
2020
Q3
$28K Buy
24,605
+13,900
+130% +$15.3K ﹤0.01% 978
2020
Q2
$9K Sell
10,705
-16,995
-61% -$12.6K ﹤0.01% 1002
2020
Q1
$20K Buy
+27,700
New +$30.9K ﹤0.01% 1060
2015
Q4
Sell
-21,159
Closed -$89K 845
2015
Q3
$89K Sell
21,159
-7,941
-27% -$50.1K ﹤0.01% 788
2015
Q2
$237K Buy
+29,100
New +$243K ﹤0.01% 798
2015
Q1
Sell
-14,300
Closed -$167K 810
2014
Q4
$167K Buy
+14,300
New +$171K ﹤0.01% 734

Mackenzie Financial's CSLT Position: Q1 2022 in Review

Mackenzie Financial sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 28,293 shares — an estimated $44K sold.

Mackenzie Financial first reported a position in CSLT in Q4 2014 and held it in 9 quarters. The position peaked at $237K in Q2 2015. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Mackenzie Financial reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Mackenzie Financial sold 28,293 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $44K.
  • Mackenzie Financial first reported a position in CASTLIGHT HEALTH, INC. in Q4 2014 and held it in 9 quarters.
  • Mackenzie Financial's CASTLIGHT HEALTH, INC. position peaked at $237K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on Mackenzie Financial's 13F filing for Q1 2022, filed 13 May 2022.